KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Share-based Compensation (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 -2.91%
Dec 28, 2025 -10.95%
Sep 28, 2025 -15.37%
Jun 29, 2025 42.36%
Mar 30, 2025 21.01%
Dec 29, 2024 -19.32%
Sep 29, 2024 -13.49%
Jun 30, 2024 12.91%
Mar 31, 2024 69.66%
Dec 31, 2023 -39.86%
Oct 1, 2023 -22.51%
Jul 2, 2023 24.84%
Apr 2, 2023 40.37%
Oct 3, 2021 -26.84%
Jul 4, 2021 15.31%
Apr 4, 2021 91.88%
Jan 3, 2021 -37.50%
Sep 27, 2020 -21.47%
Jun 28, 2020 23.95%
Mar 29, 2020 64.38%
Dec 29, 2019 -34.69%
Sep 29, 2019 -21.97%
Jun 30, 2019 21.71%
Mar 31, 2019 65.38%
Dec 30, 2018 -35.54%
Sep 30, 2018 -22.44%
Jul 1, 2018 16.42%
Apr 1, 2018 31.37%
Dec 31, 2017 -13.56%
Oct 1, 2017 -19.45%
Jul 2, 2017 27.95%
Apr 2, 2017 13.93%
Sep 27, 2015 -24.81%
Jun 28, 2015 32.35%
Mar 29, 2015 39.73%
Dec 28, 2014 -29.13%
Sep 28, 2014 -14.88%
Jun 29, 2014 22.22%
Mar 30, 2014 37.50%
Dec 29, 2013 -10.56%
Sep 29, 2013 -29.69%
Jun 30, 2013 18.04%
Mar 31, 2013 31.97%
Dec 30, 2012 0.68%
Sep 30, 2012 -25.51%
Jul 1, 2012 13.29%
Apr 1, 2012 17.69%
Oct 3, 2010 14.19%
Jul 4, 2010 -5.73%
Apr 4, 2010 21.71%
Jan 3, 2010 -18.35%
Sep 27, 2009 -13.19%
Jun 28, 2009 14.47%